[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369687-105":59,"doc-detail-369687-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-protocatechuic-acid-encapsulated-bovine-serum-albumin-functionalized-folic-acid-nanoparticles-targeted-therapy-in-urethane-induced-lung-cancer-model","Novel protocatechuic acid encapsulated bovine serum albumin functionalized folic acid nanoparticles - targeted therapy in urethane-induced lung cancer model","","Global lung cancer mortality is increasing, creating demand for innovative natural compounds with fewer side effects. Protocatechuic acid (PCA) shows cytotoxic activity against human lung cancer cells but has poor water solubility that restricts its use in cancer therapy. This study encapsulates PCA within bovine serum albumin (BSA) nanoparticles conjugated with folic acid (FA) to improve solubility and enable targeted delivery. The resulting PCA-BSA@FA-NPs are characterized (229 nm) and tested in vitro and in a mouse lung cancer model, showing markedly reduced toxicity and decreased NF-κB, MAPK, and FAK expression compared with PCA treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-protocatechuic-acid-encapsulated-bovine-serum-albumin-functionalized-folic-acid-nanoparticles-targeted-therapy-in-urethane-induced-lung-cancer-model/369687/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-protocatechuic-acid-encapsulated-bovine-serum-albumin-functionalized-folic-acid-nanoparticles-targeted-therapy-in-urethane-induced-lung-cancer-model/369687.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was protocatechuic acid (PCA) formulated into nanoparticles?","Question",{"text":112,"@type":113},"PCA has cytotoxic effects against lung cancer cells, but its poor water solubility limits its application in biological settings. Encapsulation in BSA nanoparticles aims to enhance solubility and delivery.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does folic acid (FA) play in the nanoparticle design?",{"text":117,"@type":113},"Folic acid targets malignant tumors by binding to folate receptors that are overexpressed on cancer cell membranes. Conjugating FA is intended to improve targeting efficacy.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological effects were observed in the lung cancer mouse model?",{"text":121,"@type":113},"In the PCA-BSA@FA-NPs treated group, NF-κB expression decreased and reductions in MAPK and FAK were also observed, with stronger declines reported compared to the PCA-treated group.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369687,1790865217,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNovel protocatechuic acid encapsulated bovine serum albumin functionalized folic acid nanoparticles for targeted therapy in urethane-induced lung cancer model  \nAlaa I. Ibrahim, HebaA. Sahyon􀀍, Adel M. Attia & AshrafA. El-Shehawy  \nLung cancer mortality rates are rising globally, increasing the need for innovative, natural compounds with fewer side effects. Protocatechuic acid (PCA) is a natural phenolic compound with cytotoxic effects against human lung cancer cells, but its poor water solubility limits its use. We hypothesized that encapsulating PCA within bovine serum albumin (BSA) nanoparticles would enhance its solubility compared to previous PCA-loaded-nanocarriers. So, we encapsulated PCA within BSA-nanoparticles conjugated with folic acid (FA) and evaluated its targeting efficacy in lung cancer cell line and lung cancer mouse model. The resulting nanocomposite (PCA-BSA@FA-NPs) had a 229 nm size. Our in vitro study indicated that PCA-BSA@FA-NPs demonstrated a 92.03% reduction in toxicity compared todoxorubicin, and a 59.67% reduction compared to PCA when tested against normal WI38 cells. In the lung cancer mouse model, the NF-κB expression decreased by 179% in the PCA-BSA@FA-NPs-treated group compared to the PCA-treated group. Both groups showed significant reductions in MAPK and FAK, with greater declines of 172% for MAPK and 316% for FAK in the PCA-BSA@FA-NPs-treated group. In conclusion, PCA-BSA@FA-NPs may serve as a promising therapy for targeting lung cancer with reduced toxicity.  \nKeywords Protocatechuic acid, Albumin nanoparticles, CD44, NF-kB, FAK, MAPK  \nLung cancer ranks as the second most prevalent form of cancer and is a major contributor to cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) making up 80% of cases1. Treatment options for NSCLC include surgery, chemotherapy, immunotherapy, and radiotherapy, depending on the cancer’s stage and other factors2. For patients who are unable to undergo surgery due to specific clinical circumstances, noninvasive therapies may offer a viable option. However, the effectiveness of these noninvasive treatments can be limited by toxicity to vital organs or tumor resistance, which can significantly affect both the quality of life and treatment outcomes for patients3.  \nProtocatechuic acid (PCA) is a natural phenolic compound found in blackberries, black currants, cauliflower, and lentils. PCA is known for its cytotoxic effects on human lung cancer cell lines, as well as its antioxidant properties4. Several studies indicate that PCA is cytotoxic against several in vitro human cancer cell lines5. Its anticancer effects are attributed to mechanisms such as plasma membrane destruction, infiltration into cancer cells, and the induction of apoptosis, which together lead to the inhibition of cancer cell growth6. PCA’s poor solubility in water limits its application in the biological field, particularly in cancer treatment7. In a previous study, PCA was loaded onto chitosan nanoparticles to enhance their therapeutic efficacy against human lung cancer cells and improve their antioxidant activity8. However, the poor solubility of chitosan poses an obstacle to its potential application as a drug carrier, as chitosan nanoparticles are poorly soluble in water and dissolve only in organic solvents9. Therefore, the researchers turned to modified chitosan nanoparticles, which enhanced the efficacy of PCA by improving their delivery capacity and amplifying their toxic effects against human lung  \nFaculty of Science, Chemistry Department, Kafrelsheikh University, El Giesh Street, Kafrelsheikh 33516, Egypt.  \n􀀍 email: [heba_sahuon@sci.kfs.edu.eg](heba_sahuon@sci.kfs.edu.eg)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \ncancer cells. This leads to more effective anticancer responses9. From our perspective, albumin would be a better alternative to chitosan. ","cbCaihJgMHYMRjRY","https://ap.wps.com/l/cbCaihJgMHYMRjRY","pdf",11263429,26,"English","# Background and rationale\n## Limitations of protocatechuic acid\n## Nanocarrier strategy: BSA and folic acid targeting\n# Targeting and biological mechanisms\n## NF-κB, MAPK, and FAK signaling pathways\n# Formulation and evaluation\n## Nanoparticle properties and characterization\n## In vitro toxicity comparison\n## In vivo effects in urethane-induced lung cancer model","[{\"question\":\"Why was protocatechuic acid (PCA) formulated into nanoparticles?\",\"answer\":\"PCA has cytotoxic effects against lung cancer cells, but its poor water solubility limits its application in biological settings. Encapsulation in BSA nanoparticles aims to enhance solubility and delivery.\"},{\"question\":\"What role does folic acid (FA) play in the nanoparticle design?\",\"answer\":\"Folic acid targets malignant tumors by binding to folate receptors that are overexpressed on cancer cell membranes. Conjugating FA is intended to improve targeting efficacy.\"},{\"question\":\"What biological effects were observed in the lung cancer mouse model?\",\"answer\":\"In the PCA-BSA@FA-NPs treated group, NF-κB expression decreased and reductions in MAPK and FAK were also observed, with stronger declines reported compared to the PCA-treated group.\"}]","Novel protocatechuic acid encapsulated bovine serum albumin functionalized folic acid nanoparticles - targeted therapy in urethane-induced lung cancer model | PDF",1790184105,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65f299ba46647620dc1f52e7e3847d34.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dc7424882dcd28217109ca84a986c80.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6515b9550551cb2d75a9066fc7f4683.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6682bc5cca2e721d12dbd9e35116e4d2.webp",980,1287]